Prostate Cancer Susceptibility Candidate (PRAC) Peptid
PRAC
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN937516
Kurzübersicht für Prostate Cancer Susceptibility Candidate (PRAC) Peptid (ABIN937516)
Target
PRAC
(Prostate Cancer Susceptibility Candidate (PRAC))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- DQGPAHLTTS KSAFLSNKKT STLKHLLGET RSDGSACNSG ISGGRGRKIP
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PRAC antibody,
Alternative Names: PRAC control peptide, PRAC antibody Blocking Peptide, Anti-PRAC Blocking Peptide, prostate cancer susceptibility candidate Blocking Peptide, C17orf92 Blocking Peptide, MGC32520 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- PRAC (Prostate Cancer Susceptibility Candidate (PRAC))
-
Hintergrund
- This gene is reported to be specifically expressed in prostate, rectum and distal colon. Sequence analysis suggests that it may play a regulatory role in the nucleus.
-
Molekulargewicht
- 6 kDa
Target
-
Sie sind hier:
